{
    "clinical_study": {
        "@rank": "1680", 
        "brief_summary": {
            "textblock": "The purpose of this study is to empirically test a series of medications to: 1) determine\n      each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective\n      dose range for each medication.  In this study, amantadine is tested.\""
        }, 
        "brief_title": "Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4", 
        "condition": "Cocaine-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "detailed_description": {
            "textblock": "16-week participation plus a 2 weekk lead-in period. Participants are assigned randomly to\n      placebo or amantadine. Participants attend group meeting 3 times/week"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        M/F, ages 18-65. cocaine dependence according to DMS-IV criteria. Self-reported use within\n        the last 30 days. Agreeable to conditions of the study and signed informed consent.\n\n        Exclusion Criteria:\n\n        Psychiatric disorder that requires medication therapy, history of seizures. Pregnant\n        and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hypnotics.\n        Acute hepatitis. Other medical conditions that deem participation to be unsafe."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "0", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000301", 
            "org_study_id": "NIDA-09260-4", 
            "secondary_id": "P50-09260-4"
        }, 
        "intervention": {
            "intervention_name": "Amantadine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Amantadine"
        }, 
        "lastchanged_date": "August 16, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90025"
                }, 
                "name": "Friends Research Institute"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Rapid Evaluation of Cocaine Pharmacotherapies (Amantadine)", 
        "overall_official": {
            "affiliation": "Friends Research Institute, Inc.", 
            "last_name": "Walter Ling, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_outcome": [
            {
                "measure": "Retention"
            }, 
            {
                "measure": "Cocaine use"
            }, 
            {
                "measure": "Cocaine craving"
            }, 
            {
                "measure": "Psychosocial progress"
            }
        ], 
        "reference": {
            "PMID": "12062456", 
            "citation": "Shoptaw S, Kintaudi PC, Charuvastra C, Ling W. A screening trial of amantadine as a medication for cocaine dependence. Drug Alcohol Depend. 2002 May 1;66(3):217-24."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000301"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "March 1996", 
        "study_design": "Allocation: Randomized, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 1997"
    }, 
    "geocoordinates": {
        "Friends Research Institute": "34.052 -118.244"
    }
}